Design, Manufacturing Defect, Breach of Warranty Claims to Proceed in La. Paxil Case

MONROE, La. — A Louisiana federal judge has allowed claims of design defect, manufacturing defect and breach of express warranty to proceed against GlaxoSmithKline in a Paxil injury case, finding they were adequately pled under Louisiana law.

In a Jan. 6 order, Judge Donald E. Walter of the U.S. District Court for the Western District of Louisiana dismissed the plaintiff’s design defect claim, however.

Cinda McLaughlin, a Louisiana resident, sued GSK in June 2012 in the U.S. District Court for the Eastern District of Pennsylvania, asserting her ingestion of Paxil caused excess serotonin, which in turn damaged her heart valves …